1. DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA. (4th December 2020) Authors: Khan, Aaminah; Gamble, Laura; Upton, Dannielle; Yu, Denise; Ehteda, Anahid; Pandher, Ruby; Mayoh, Chelsea; Burns, Mark; Norris, Murray; Haber, Michelle; Tsoli, Maria; Ziegler, David Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DIPG-16. COMBINATION OF ARGININE DEPLETION AND POLYAMINE INHIBITION AS AN ANTICANCER STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG). (4th December 2020) Authors: Khan, Aaminah; Gamble, Laura; Pandher, Ruby; Burns, Mark R; Mussai, Francis; Norris, Murray; Haber, Michelle; Tsoli, Maria; Ziegler, David S Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DIPG-21. DIPG cells alter the permeability of the blood-brain barrier in the brainstem leading to treatment failure. (3rd June 2022) Authors: Ung, Caitlin; Upton, Dannielle H; Venkat, Pooja; Pandher, Ruby; Curnis, Flavio; Corti, Angelo; Nicolazzo, Joesph; Mayoh, Chelsea; Tsoli, Maria; Ziegler, David S Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DIPG-27. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION. (4th December 2020) Authors: Ehteda, Anahid; Franshaw, Laura; Liu, Jie; Joshi, Swapna; Simon, Sandy; Pang, Chi Nam Ignatius; Giorgi, Federico; Pandher, Ruby; Ung, Caitlin; Tolhurst, Ornella; Mayoh, Chelsea; Khan, Aaminah; Hayden, Elisha; Gopalakrishnan, Anjana; Trebilcock, Peter; Upton, Dannielle; Lehmann, Rebecca; George, S... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias. Issue 6 (22nd June 2022) Authors: Cantilena, Sandra; Gasparoli, Luca; Pal, Deepali; Heidenreich, Olaf; Klusmann, Jan‐Henning; Martens, Joost H. A.; Faille, Alexandre; Warren, Alan J.; Karsa, Mawar; Pandher, Ruby; Somers, Klaartje; Williams, Owen; de Boer, Jasper Journal: Clinical and translational medicine Issue: Volume 12:Issue 6(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HGG-09. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION IN DIPG. (1st June 2021) Authors: Ehteda, Anahid; Simon, Sandy; Franshaw, Laura; Giorgi, Federico M; Liu, Jie; Hayden, Elisha; Rouaen, Jourdin; Pang, Chi Nam Ignatius; Pandher, Ruby; Mayoh, Chelsea; Tang, Yujie; Khan, Aaminah; Ung, Caitlin; Kankean, Anne; Lehmann, Rebecca; Shen, Sylvie; Gopalakrishnan, Anjana; Trebilcock, Peter; ... Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. RARE-02. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA. (1st June 2021) Authors: Khan, Aaminah; Gamble, Laura; Upton, Dannielle; Yu, Denise; Pandher, Ruby; Mayoh, Chelsea; Burns, Mark R; Norris, Murray D; Haber, Michelle; Tsoli, Maria; Ziegler, David S Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗